Skip to main page content

Latest Updates in Uveitis

My Session Status

When:
1:30 PM, Friday 14 Jun 2019 (1 hour 30 minutes)
Breaks:
Break in the Exhibit Hall    03:00 PM to 03:45 PM (45 minutes)
Where:
Québec City Convention Centre - Room 202 | Salle 202
Theme:
Uveitis

LEARNING OBJECTIVES
At the end of this session, participants will be able to:

  • Integrate new research into clinical practice
  • Apply results of diagnostic testing into clinical decision making
  • Describe optimal immunosuppressive agents for ocular inflammation
  • Recognize rare causes of uveitis
CANMEDS ROLES: Medical Expert, Scholar

Sub Sessions

1:30 PM - 1:35 PM | 5 minutes
1:35 PM - 1:55 PM | 20 minutes
Uveitis
1:55 PM - 2:03 PM | 8 minutes
Uveitis

Author Block: Saanwalshah S. Saincher, Chloe Gottlieb Author Disclosure Block: S.S. Saincher: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); The Ottawa Hospital Research Institute. Description of relationship(s); Summer Student. C. Gottlieb: None.Abstract Body:Purpose: The relationship between d...

2:03 PM - 2:11 PM | 8 minutes
Uveitis

Author Block: Marie-Josée Aubin, Cristina Bostan, Mariam T. Ibrahim, Mark Bamberger, Karin M. Oliver Author Disclosure Block: M. Aubin: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); University of Ottawa Eye Institute, Gilead. Description of relationship(s); Honoraria. Funded grants or clinical trials; Name of for-profit or not-for-profit organization(s); Gilead, PeriPh...

2:11 PM - 2:19 PM | 8 minutes
Uveitis

Author Block: Maryam I. T. Al-Najjar, Eric FortinAuthor Disclosure Block: M.I.T. Al-Najjar: None. E. Fortin: Membership on advisory boards or speakers’ bureaus; Name of for-profit or not-for-profit organization(s); advisory boards for AbbVie. Funded grants or clinical trials; Name of for-profit or not-for-profit organization(s); grants from allergan, gilaed and abbvie.Abstract Body:

2:19 PM - 2:27 PM | 8 minutes
UveitisSecond Prize, COS Awards of Excellence

SECOND PRIZE, COS AWARDS FOR EXCELLENCE IN OPHTHALMIC RESEARCHAuthor Block: James J. Armstrong, Liu Hong, Cindy M. L. HutnikAuthor Disclosure Block: J.J. Armstrong: None. L. Hong: None. C.M.L. Hutnik: None.Abstract Body:Purpose...

2:27 PM - 2:35 PM | 8 minutes
Uveitis

Author Block: Maryam I. T. Al-Najjar, Marie Josee Aubin, Cristina BostanAuthor Disclosure Block: M.I.T. Al-Najjar: None. M. Aubin: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Honoraria: University of Ottawa Eye Institute, Gilead. Membership on advisory boards or speakers’ bureaus; Name of for-profit or not-for-profit organization(s...

2:35 PM - 2:43 PM | 8 minutes
Uveitis

Author Block: Fargol Mostofian, Solin Saleh, Irfan Kherani, Chloe GottliebAuthor Disclosure Block: F. Mostofian: None. S. Saleh: None. I. Kherani: None. C. Gottlieb: None.Abstract Body:Purpose: Worldwide, Toxoplasmosis is the leading cause of posterior uveitis. Atypical presentations increase misdiagnosis and risk...

2:43 PM - 2:50 PM | 7 minutes
Uveitis

Author Block: Zainab Khan, Sabrina Bergeron, Miguel Burnier, Marie-Josee AubinAuthor Disclosure Block: Z. Khan: None. S. Bergeron: None. M. Burnier: None. M. Aubin: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); University of Ottawa, Gilead. Description of relationship(s); Invited speaker, Uveitis inv...

2:50 PM - 3:00 PM | 10 minutes

My Session Status

Send Feedback

Session detail
Allows attendees to send short textual feedback to the organizer for a session. This is only sent to the organizer and not the speakers.
When enabled, you can choose to display attendee lists for individual sessions. Only attendees who have chosen to share their profile will be listed.
Enable to display the attendee list on this session's detail page. This change applies only to this session.

Changes here will affect all session detail pages unless otherwise noted